COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2019

Dec 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2019-12-02

Reporting Person: Freund John Gordon (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-02	Common Stock	J	574916	—	Disposed	0	Indirect
2019-12-02	Common Stock	J	8625	—	Acquired	8625	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6960	Direct
Common Stock	34788	Indirect

Footnotes

F1: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2: The shares were held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein.

F3: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to Dr. Freund.

F4: The shares are held by Skyline Venture Management V, LLC. See footnote (2).

F5: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.